MedPath

A study to understand surveillance of Antimicrobial Resistance in Aurangabad, Maharashtra

Not Applicable
Completed
Registration Number
CTRI/2022/02/040008
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
22
Inclusion Criteria

Healthcare providers at district hospital, RH and PHC, private clinics, private hospitals, government and private microbiologists, government and private pharmacists.

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of the study would be to yield data on the existing mechanisms of the laboratory processes and surveillance for Antimicrobial Resistance.Timepoint: This shall be achieved till 30th April
Secondary Outcome Measures
NameTimeMethod
The secondary outcome would be to understand the challenges and facilitators for the implementation of National and State Action Plan for Antimicrobial resistance in Aurangabad.Timepoint: This shall be achieved after 6 weeks of data collection
© Copyright 2025. All Rights Reserved by MedPath